Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer's disease.
Alzforum,
Zhao TT, Zhang Y, Zhang CQ, Chang YF, Cui MR, Sun Y, Hao WQ, Yan YM, Gu S, Xie Y, Wei BB.